Olanib 150 mg (Olaparib) is a PARP inhibitor used in ovarian, breast, pancreatic, and prostate cancers with BRCA mutations. It blocks cancer cell DNA repair, leading to cell death. Common side effects include nausea, fatigue, anemia, and low blood counts. Use under strict medical supervision. https://www.jkmedicine.com/product/details/38